Relationship between Intracellular Concentration and Radiosensitizing Effect of Pimonidazole and Etanidazole on Two Human Melanoma Cell Lines

References

• Allen J.G., Dische S., Lenox-Smith I., Malcolm S.L., Saunders M.I. The pharmacokinetics of a new radiosensitizer, Ro 03-8799 in humans. European Journal of Clinical Pharmacology 1984; 27: 483–489
   PubMed Web of Science ®Google Scholar
• Awwad H.K., El Badawy S., Abd el Baki H., Zaghloul M., Osman A.E.M., Akoush H., Fairchild K. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer: evidence of diffusion from urine. International Journal of Radiation Oncology Biology and Physics 1989; 16: 1083–1084
   PubMed Web of Science ®Google Scholar
• Bleehen N.M., Newman H.F.V., Maughan T.S., Workman P. A multiple dose study of the combined radiosensitizers Ro 03-8799 (Pimonidazole) and SR-2508 (Etanidazole). International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1093–1096
   PubMed Web of Science ®Google Scholar
• Brown D.M., Gonzalez-Mendez R., Brown J.M. Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro. Radiation Research 1983; 93: 492–505
   PubMed Web of Science ®Google Scholar
• Brown J.M., Workman P. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiation Research 1980; 82: 171–190
   PubMed Web of Science ®Google Scholar
• Brown J.M., Yu N.Y. Radiosensitization of hypoxic cells in vivo by SR-2508 at low radiation doses: a preliminary report. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1207–1212
   PubMed Web of Science ®Google Scholar
• Chassagne D.J., Brisgand D., Malaise E.P., Eschwege F., Sancho-Garnier H. European etanidazole phase III trial (progress report). Radiation Research, A Twentieth-Century Perspective, W.C. Dewey, M. Edington, R.J.M. Fry, E.J. Hall, G.F. Whitmore. Academic Press, San Diego 1992; 2: 590–594, In
   Google Scholar
• Coleman C.N., Urtasun R.C., Wasserman T.H., Hancock S., Harris J.W., Halsey J., Hirst V.K. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1749–1753
   PubMed Web of Science ®Google Scholar
• Coleman C.N., Riese N., Buswell L., Hurwitz S., Lee D.J., Wasserman T.H., Cosmatos D. Clinical trials of etanidazole (SR 2508): RTOG and joint center for radiation therapy trials. Radiation Research, A Twentieth-Century Perspective, W.C. Dewey, M. Edington, R.J. Michael Fry, E.J Hall, G.f. Whitmore. Academic Press, San Diego 1992; 2: 595–600, In
   Google Scholar
• Dennis M.F., Stratford M.R.L., Wardman P., Watts M.E. Cellular uptake of misonidazole and analogues with acidic or basic functions. International Journal of Radiation Biology 1985; 47: 629–643
   Web of Science ®Google Scholar
• Dische S. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma. Radiotherapy and Oncology 1987; 10: 111–116
   PubMed Web of Science ®Google Scholar
• Dische S. Radiotherapy, carcinoma of cervix and the radiosensitizer Ro 03-8799 (Pimonidazole). Radiation Research, A Twentieth-Century Perspective, W.C. Dewey, M. Edington, E.J. Michael Fry, E.J. Hall, G.F. Whitmore. Academic Press, San Diego 1992; 2: 584–589, In
   Google Scholar
• Dische S., Saunders M.I., Dunphy E.P., Bennet M.H., Des Rochers C., Stratford M.R.L., Minchington A.I., Orchard R.A. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799. International Journal of Radiation Oncology, Biology and Physics 1986a; 12: 1109–1111
   PubMed Web of Science ®Google Scholar
• Dische S., Saunders M.I., Bennett M.H., Dunphy E.P., Des Rochers C., Stratford M.R.L., Minchinton A.I., Wardman P. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. British Journal of Radiology 1986b; 59: 911–917
   PubMed Web of Science ®Google Scholar
• Dische S., Bennett M.H., Orchard R., Stratford M.R.L., Wardman P. The uptake of the radiosensitizing compound Ro 03-8799 (pimonidazole) in human tumors. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1089–1092
   PubMed Web of Science ®Google Scholar
• Fertil B., Dertinger H., Courdi A., Malaise E.P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiation Research 1984; 99: 73–84
   PubMed Web of Science ®Google Scholar
• Foster M., Trembly G.S., Stamas T.A. A turbidimetric assay for tyrosinase activity in frozen sections of mouse skin (21083). Proceedings of the Society of Experimental Biology and Medicine 1954; 86: 313–315
   PubMed Web of Science ®Google Scholar
• Foster M., Cook R., Stamas T.A. In vitro studies of the effects of melanocyte population density on melanin formation. Journal of Experimental Zoology 1956; 132: 1–23
   Google Scholar
• Fox M. A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1980; 1: 71–77
   PubMedGoogle Scholar
• Guichard M., Gosse C., Malaise E.P. Survival curve of a human melanoma in nude mice. Journal of the National Cancer Institute 1977; 58: 1665–1669
   PubMedGoogle Scholar
• Guichard M., Lespinasse F., Malaise E.P. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts. Radiation Research 1986; 105: 115–125
   PubMed Web of Science ®Google Scholar
• Hill S.A., Fowler J.F., Minchinton A.I., Stratford M.R.L., Denekamp J. Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration. International Journal of Radiation Biology 1983; 44: 143–150
   Web of Science ®Google Scholar
• Honess D.J., Wasserman T.H., Workman P., Ward R., Bleehen N.M. Additivity of radiosensitization by the combination of SR-2508 (Etanidazole) and Ro 03-8799 (Pimonidazole) in a murine tumor system. International Journal of Radiation Oncology, Biology and Physics 1988; 15: 671–675
   PubMed Web of Science ®Google Scholar
• Koch C.J., Howell R.L., Biaglow J.E. Ascorbate anion potentiates cytotoxicity of nitroaromatic compounds under hypoxic and anoxic conditions. British Journal of Cancer 1979; 39: 321–329
   PubMed Web of Science ®Google Scholar
• Laurent F., Canal P., Soula G. Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1101–1103
   PubMed Web of Science ®Google Scholar
• Lespinasse F., Thomas Ch., Bonnay M., Malaise E.P., Guichard M. Ro 03-8799: preferential relative uptake in human tumor xenografts compared to a murine tumor: comparison with SR-2508. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1105–1109
   PubMed Web of Science ®Google Scholar
• Malcolm S.L., Lee A., Groves J.K. High performance liquid chromatographic analysis of the new hypoxic cell radiosensitizer, Ro 03-8799, in biological samples. Journal of Chromatography 1983; 273: 327–333
   PubMed Web of Science ®Google Scholar
• Minchington A.I., Stratford M.R.L. A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1117–1120
   PubMed Web of Science ®Google Scholar
• Newman H.F.V., Bleehen N.M., Workman P. A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations. British Journal of Radiology 1986; 59: 423–425
   PubMed Web of Science ®Google Scholar
• Newman H.F.V., Ward R., Workman P., Bleehen N.M. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (Pimonidazole) and SR-2508 (Etanidazole). International Journal of Radiation Oncology, Biology and Physics 1988; 15: 1073–1083
   PubMed Web of Science ®Google Scholar
• Roberts J.T., Bleehen N.M., Walton M.I., Workman P. A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. British Journal of Radiology 1986; 59: 107–116
   PubMed Web of Science ®Google Scholar
• Rootman J., Gallie B., Kumi C., Bussanich N., Rogers B., Palcic B. Ocular penetration, toxicity and radiosensitization effects of two hypoxic cell radiosensitzers on retinoblastoma. Archives of Ophthalmology 1986; 104: 1693–1697
   PubMedGoogle Scholar
• Saunders M.I., Anderson P.J., Bennett M.H., Dische S., Minchinton A., Stratford M.R.L., Tothill M. The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrations. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1759–1763
   PubMed Web of Science ®Google Scholar
• Sokal R.R., Rohlf F.J. Biometry. The Principles and Practices of Statistics in Biological Research, R. Emerson, R.R. Sokal, F.J. Rohlf. W. H. Freeman, San Francisco 1969; 405–493
   Google Scholar
• Stone H.B., Luu Y.H., Lam K.N. Sensitization by SR-2508 plus Ro 03-8799. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1097–1100
   PubMed Web of Science ®Google Scholar
• Stone H.B., Hirst V.K., Cribbs R., Luu Y.H., Brown J.M. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. International Journal of Radiation Oncology, Biology and Physics 1991; 20: 987–995
   PubMed Web of Science ®Google Scholar
• Stratford M.R.L., Dennis M.F., Watts M.E., Watfa R.R. Radiosensitizer-DNA interactions. British Journal of Radiology 1988; 61: 860–861
   PubMed Web of Science ®Google Scholar
• Stratford M.R.L., Dennis M.F., Watts M.E., Watfa R.R., Woodcock M. Radiosensitizer-DNA interactions in relation to intracellular uptake. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1007–1010
   PubMed Web of Science ®Google Scholar
• Taghian A., Lespinasse F., Guichard M. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts. International Journal of Radiation Oncology, Biology and Physics 1991; 21: 1535–1540
   PubMed Web of Science ®Google Scholar
• Taylor Y.C., Rauth A.M. Differences in the toxicity and metabolism of the 2-Nitroimidazole Misonidazole (Ro 07-0582) in HeLa and Chinese hamster ovary cells. Cancer Research 1978; 38: 2745–2752
   PubMed Web of Science ®Google Scholar
• Vindelov L.L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Archiv B. Cell Pathology 1977; 24: 227–242
   PubMedGoogle Scholar
• Walling J.M., Deacon J., Holliday S., Stratford I.J. High uptake of RSU 1069 and its analogues into melanotic melanomas. Cancer Chemotherapy and Pharmacology 1989; 24: 28–32
   PubMed Web of Science ®Google Scholar
• Walton M.I., Bleehen N.M., Workman P. The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice. British Journal of Cancer 1987; 55: 469–476
   PubMed Web of Science ®Google Scholar
• Watts M.E., Jones N.R. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues. International Journal of Radiation Biology 1985; 47: 645–653
   Web of Science ®Google Scholar
• Watts M.E., Dennis M.F., Jones N.R., Stratford M.R.L. A comparison of the intracellular uptake and radiosensitization efficiency in different media of uncharged 2-nitroimidazoles of varying lipophilicity. International Journal of Radiation Biology 1987a; 52: 359–370
   Web of Science ®Google Scholar
• Watts M.E., Dennis M.F., Woodcock M. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro. British Journal of Radiology 1987b; 60: 1233–1235
   PubMed Web of Science ®Google Scholar
• Watts M.E., Dennis M.F., Roberts I.J. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines. International Journal of Radiation Biology 1990; 57: 361–372
   PubMed Web of Science ®Google Scholar
• White R.A.S., Workman P., Brown J.M. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 in the dog—hydrophilic radiosensitizers potentially less toxic than misonidazole. Radiation Research 1980; 84: 542–561
   PubMed Web of Science ®Google Scholar
• Whittaker J.R. Changes in melanogenesis during dedifferentiation of chick retinal pigment cells in cell culture. Developmental Biology 1963; 8: 99–127
   PubMed Web of Science ®Google Scholar